Origenis receives Grant by the BmBF to Deepen Research in the Anti-inflammatory Sector
March 15, 2009
Origenis receives a research grant from the Federal Ministry of Education and Research to extend its research in the antiinflammatory area. Within this project a consortium of experts, led by Origenis, develops small molecules against the interleukin-mediated autoimmune disease Colitis ulcerosa. The grant will provide a non-repayable fund to Origenis in the amount of 1.2 million €.